Taken together, the combination of OS, RFS, DSS, DMFS, and PPS and concern of bias, our findings illustrated the expression levels and prognostic value of GSDMC in several kinds of cancers, GSDMC might perform as a negative prognostic biomarker in BRCA patients. This evidence concerns the gene GSDMC and cancer.